The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression

Completed

Plain-English translation of NCT03775200 on ClinicalTrials.gov ↗ · Source last updated April 2023 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(25 sites)

United States

Kadima Neuropsychiatry Institute, La Jolla, California

Altman Clinical and Translational Research Institute, University of California, San Diego, California

Stanford Department of Psychiatry, Stanford, California

Mood and Anxiety Disorders Program Emory University School of Medicine, Atlanta, Georgia

Ray Worthy Psychiatry LLC, New Orleans, Louisiana